Market Research Logo

Global Follicular Lymphoma Therapeutics Market 2018-2022

Global Follicular Lymphoma Therapeutics Market 2018-2022

About Follicular Lymphoma

Follicular lymphoma is a subtype of B-cell non-Hodgkin lymphoma (NHL). It is usually indolent (slow-growing) and the tumor cells grow as groups to form nodules. Symptoms of follicular lymphoma include enlarged lymph nodes, shortness of breath, fever, night sweats, and weight loss.

Technavio’s analysts forecast the Global Follicular Lymphoma Therapeutics Market to at a CAGR of 7.50% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the follicular lymphoma therapeutics market. To calculate the market size, the report considers the revenue generated from the application of follicular lymphoma therapeutics across the globe.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, follicular lymphoma therapeutics market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Bayer
  • Biogen
  • F. Hoffmann-La Roche
  • Gilead
  • Merck
Market driver
  • Increasing government initiatives
  • For a full, detailed list, view our report
Market challenge
  • High cost of treatment
  • For a full, detailed list, view our report
Market trend
  • Increasing patient programs
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


PRESS RELEASE

Technavio Announces the Publication of its Research Report - Global Follicular Lymphoma Therapeutics Market 2018-2022

Technavio recognizes the following companies as the key players in the global follicular lymphoma therapeutics market: Bayer, Biogen, F. Hoffmann-La Roche, Gilead, and Merck.

Commenting on the report, an analyst from Technavio’s team said: “One trend affecting this market are the increasing patient programs. Some of the top pharmaceutical companies are offering patient support programs to provide information about the best therapeutics to increase the awareness about the treatment and range of cost.”

According to the report, one driver influencing this market is the increasing government initiatives. The global follicular lymphoma therapeutics market is likely to be driven by rise in government funded initiatives such as Cancer Breakthrough 2020.

Further, the report states that one challenge affecting this market is the high cost of treatment. The high cost of the available marketed products is expected to pose a challenge for the growth of the global follicular lymphoma therapeutics market.

Companies Mentioned

Bayer
Biogen
F. Hoffmann-La Roche
Gilead
Merck

  • Executive summary
  • Scope of the report
  • Research methodology
  • Market landscape
    • Market ecosystem
      • Table Parent market
      • Table Global NHL therapeutics market segmentation
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Market sizing
    • Market definition
      • Table Market definition: Inclusions and exclusions checklist
    • Market sizing 2017
      • Table Market size 2017
      • Table Validation techniques employed for market sizing 2017
    • Market size and forecast
      • Table Global follicular lymphoma therapeutics market - Market size and forecast 2017-2022 ($ mn)
      • Table Global follicular lymphoma therapeutics market - Year-over-year growth 2018-2022 (%)
  • Five forces analysis
    • Table Five forces analysis 2017
    • Table Five forces analysis 2022
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition: Five forces 2017
  • Pipeline landscape
    • Table Pipeline landscape by development phase 2017-2018
    • Table Late stage pipeline molecules for the treatment of follicular lymphoma 2017-2018
  • Market segmentation by molecule type
    • Segmentation by molecule type
      • Table Global follicular lymphoma therapeutics market - Market share by molecule type 2017- 2022 (%)
    • Comparison by molecule type
      • Table Comparison by molecule type
    • Biologicals - Market size and forecast 2017-2022
      • Table Global follicular lymphoma therapeutics market by biologicals - Market size and forecast 2017-2022 ($ mn)
      • Table Global follicular lymphoma therapeutics market by biologicals - Year-over-year growth 2018-2022 (%)
    • Small molecules - Market size and forecast 2017- 2022
      • Table Global follicular lymphoma therapeutics market by small molecules - Market size and forecast 2017-2022 ($ mn)
      • Table Global follicular lymphoma therapeutics market by small molecules - Year-over-year growth 2018-2022 (%)
    • Market opportunity by molecule type
      • Table Market opportunity by molecule type
  • Customer landscape
    • Table Customer landscape
  • Regional landscape
    • Geographical segmentation
      • Table Global follicular lymphoma therapeutics market - Market share by geography 2017-2022 (%)
    • Regional comparison
      • Table Regional comparison
    • Americas - Market size and forecast 2017-2022
      • Table Follicular lymphoma therapeutics market in Americas - Market size and forecast 2017- 2022 ($ mn)
      • Table Follicular lymphoma therapeutics market in Americas - Year-over-year growth 2018- 2022 (%)
      • Table Top 3 countries in Americas
    • EMEA - Market size and forecast 2017-2022
      • Table Follicular lymphoma therapeutics market in EMEA - Market size and forecast 2017-2022 ($ mn)
      • Table Follicular lymphoma therapeutics market in EMEA - Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in EMEA
    • APAC - Market size and forecast 2017-2022
      • Table Follicular lymphoma therapeutics market in APAC - Market size and forecast 2017-2022 ($ mn)
      • Table Follicular lymphoma therapeutics market in APAC - Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in APAC
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
  • Market trends
    • Increasing patient support programs
    • Strategic alliances
    • Advanced technologies
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
  • Vendor landscape
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • Bayer
      • Table Bayer - Overview
      • Table Bayer - Business segments
      • Table Bayer - Organizational developments
      • Table Bayer - Geographic focus
      • Table Bayer - Segment focus
      • Table Bayer - Key offerings
      • Table Bayer - Key customers
    • Biogen
      • Table Biogen - Overview
      • Table Biogen - Business segments
      • Table Biogen - Organizational developments
      • Table Biogen - Geographic focus
      • Table Biogen - Key offerings
      • Table Biogen - Key customers
    • F. Hoffmann-La Roche
      • Table F. Hoffmann-La Roche - Overview
      • Table F. Hoffmann-La Roche - Business segments
      • Table F. Hoffmann-La Roche - Organizational developments
      • Table F. Hoffmann-La Roche - Geographic focus
      • Table F. Hoffmann-La Roche - Segment focus
      • Table F. Hoffmann-La Roche - Key offerings
      • Table F. Hoffmann-La Roche - Key customers
    • Gilead
      • Table Gilead - Overview
      • Table Gilead - Business segments
      • Table Gilead - Organizational developments
      • Table Gilead - Geographic focus
      • Table Gilead - Key offerings
      • Table Gilead - Key customers
    • Merck
      • Table Merck - Overview
      • Table Merck - Business segments
      • Table Merck - Organizational developments
      • Table Merck - Geographic focus
      • Table Merck - Segment focus
      • Table Merck - Key offerings
      • Table Merck - Key customers
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report